These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15009227)

  • 1. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone.
    Kivity S; Lerman P; Ariel R; Danziger Y; Mimouni M; Shinnar S
    Epilepsia; 2004 Mar; 45(3):255-62. PubMed ID: 15009227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
    Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
    Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of outcome of infants with infantile spasms treated during controlled studies of ACTH and prednisone.
    Glaze DG; Hrachovy RA; Frost JD; Kellaway P; Zion TE
    J Pediatr; 1988 Mar; 112(3):389-96. PubMed ID: 2450190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTH Treatment of Infantile Spasms: Low-Moderate- Versus High-Dose, Natural Versus Synthetic ACTH-A Retrospective Cohort Study.
    Riikonen R; Lähdetie J; Kokki H
    Pediatr Neurol; 2020 Oct; 111():46-50. PubMed ID: 32951660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACTH therapy for infantile spasms: a combination therapy with high-dose pyridoxal phosphate and low-dose ACTH.
    Takuma Y
    Epilepsia; 1998; 39 Suppl 5():42-5. PubMed ID: 9737444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A prognostic study of cryptogenic infantile spasms].
    Boulloche J; Dautreme P; Le Luyer B; Mallet E; Tron P
    Ann Pediatr (Paris); 1991 Feb; 38(2):71-4. PubMed ID: 1709342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favourable prognostic factors with infantile spasms.
    Riikonen RS
    Eur J Paediatr Neurol; 2010 Jan; 14(1):13-8. PubMed ID: 19362867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of infantile spasms.
    Haines ST; Casto DT
    Ann Pharmacother; 1994 Jun; 28(6):779-91. PubMed ID: 7919570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive deficits after cryptogenic infantile spasms with benign seizure evolution.
    Gaily E; Appelqvist K; Kantola-Sorsa E; Liukkonen E; Kyyrönen P; Sarpola M; Huttunen H; Valanne L; Granström ML
    Dev Med Child Neurol; 1999 Oct; 41(10):660-4. PubMed ID: 10587041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome in West syndrome.
    Sharma NL; Vishwanthan V
    Indian Pediatr; 2008 Jul; 45(7):559-63. PubMed ID: 18695274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.
    Vigevano F; Cilio MR
    Epilepsia; 1997 Dec; 38(12):1270-4. PubMed ID: 9578521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study.
    Baram TZ; Mitchell WG; Tournay A; Snead OC; Hanson RA; Horton EJ
    Pediatrics; 1996 Mar; 97(3):375-9. PubMed ID: 8604274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study.
    O'Callaghan FJ; Lux AL; Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; Verity CM; Osborne JP
    Epilepsia; 2011 Jul; 52(7):1359-64. PubMed ID: 21668442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
    Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms.
    Granström ML; Gaily E; Liukkonen E
    Epilepsia; 1999 Jul; 40(7):950-7. PubMed ID: 10403219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of ACTH in symptomatic infantile spasms with hypsarrhythmia.
    Sher PK; Sheikh MR
    Pediatr Neurol; 1993; 9(6):451-6. PubMed ID: 7605553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of conventional therapy for infantile spasms.
    Holden KR; Clarke SL; Griesemer DA
    Seizure; 1997 Jun; 6(3):201-5. PubMed ID: 9203248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognosis after infantile spasms: a statistical study of prognostic factors in 200 cases.
    Matsumoto A; Watanabe K; Negoro T; Sugiura M; Iwase K; Hara K; Miyazaki S
    Dev Med Child Neurol; 1981 Feb; 23(1):51-65. PubMed ID: 6259007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.